90 Recruiting Studies Using Cabozantinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cabozantinib
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer
π City of Hope Medical Center β Duarte, California
Advanced Clear Cell Renal Cell Carcinoma
View Study & Checklist βTesting the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
π Mayo Clinic Hospital in Arizona β Phoenix, Arizona
Advanced Bladder Urothelial Carcinoma
View Study & Checklist βA Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
π University of Colorado Cancer Center β Aurora, Colorado
Cancer
View Study & Checklist βStudy of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
π Washington University School of Medicine β St Louis, Missouri
Bladder Cancer
View Study & Checklist βA Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
π University of Alabama at Birmingham β Birmingham, Alabama
Medullary Thyroid Cancer
View Study & Checklist βA Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
π Ironwood Cancer & Research Centers ( Site 0077) β Chandler, Arizona
Carcinoma, Renal Cell
View Study & Checklist βTesting Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
π City of Hope Comprehensive Cancer Center β Duarte, California
Locally Advanced Extraskeletal Myxoid Chondrosarcoma
View Study & Checklist βTesting the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
π Veterans Administration Medical Center - Birmingham β Birmingham, Alabama
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
View Study & Checklist βStudy of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
π Exelixis Clinical Site #116 β La Jolla, California
Renal Cell Carcinoma
View Study & Checklist βPembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
π Moffitt Cancer Center β Tampa, Florida
Metastatic Head and Neck Carcinoma
View Study & Checklist βA Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
π Memorial Sloan Kettering Basking Ridge (All Protocol Activities) β Basking Ridge, New Jersey
Metastatic Renal Cell Carcinoma
View Study & Checklist βCabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer
π Mayo Clinic Hospital in Arizona β Phoenix, Arizona
Advanced Endometrial Carcinoma
View Study & Checklist βErlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
π Mayo Clinic in Arizona β Scottsdale, Arizona
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist βCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
π City of Hope Comprehensive Cancer Center β Duarte, California
Bladder Small Cell Neuroendocrine Carcinoma
View Study & Checklist βStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
π Exelixis Clinical Site #53 β Gilbert, Arizona
Urothelial Carcinoma
View Study & Checklist βAtezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
π University of Arizona Cancer Center β Tucson, Arizona
Pancreatic Cancer
View Study & Checklist βTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
π Northwestern University β Chicago, Illinois
Advanced Differentiated Thyroid Gland Carcinoma
View Study & Checklist βCYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
π The Rutgers Cancer Institute of New Jersey β New Brunswick, New Jersey
Kidney Cancer
View Study & Checklist βTesting the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma
π Mayo Clinic Hospital in Arizona β Phoenix, Arizona
Skin Angiosarcoma
View Study & Checklist βStudy of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
π Exelixis Clinical Site #4 β Tucson, Arizona
Metastatic Prostate Cancer
View Study & Checklist βA Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
π Clinical Research Facility β St Leonards, New South Wales
Medullary Thyroid Cancer
View Study & Checklist βImmunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
π University of South Alabama Mitchell Cancer Institute β Mobile, Alabama
Clear Cell Renal Cell Carcinoma
View Study & Checklist βCabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
π City of Hope Medical Center β Duarte, California
Metastatic Leiomyosarcoma
View Study & Checklist βCabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
π M D Anderson Cancer Center β Houston, Texas
Malignant Neoplasms of Urinary Tract
View Study & Checklist βStudy of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
π University of Colorado Hospital β Aurora, Colorado
Colorectal Adenocarcinoma
View Study & Checklist βUsing Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
π Sutter Auburn Faith Hospital β Auburn, California
Anal Melanoma
View Study & Checklist βLenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
π Moffitt Cancer Center β Tampa, Florida
Advanced Clear Cell Renal Cell Carcinoma
View Study & Checklist βStudy of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
π University of California San Diego β La Jolla, California
Castration-resistant Prostate Cancer
View Study & Checklist βTesting the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Metastatic Large Cell Neuroendocrine Carcinoma
View Study & Checklist βAtezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
π M D Anderson Cancer Center β Houston, Texas
Recurrent Glioblastoma
View Study & Checklist βTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Advanced Renal Cell Carcinoma
View Study & Checklist βNivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
π Lombardi Comprehensive Cancer Center β Washington D.C., District of Columbia
Melanoma
View Study & Checklist βCabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
π Stanford University Medical Center β Stanford, California
Metastatic Soft-tissue Sarcoma
View Study & Checklist βTesting Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
π Katmai Oncology Group β Anchorage, Alaska
Functioning Pancreatic Neuroendocrine Tumor
View Study & Checklist βTesting Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
π Banner MD Anderson Cancer Center β Gilbert, Arizona
Metastatic Papillary Renal Cell Carcinoma
View Study & Checklist βA Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
π Memorial Sloan Kettering Basking Ridge β Basking Ridge, New Jersey
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
View Study & Checklist βNeoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
π Emory University Hospital/Winship Cancer Institute β Atlanta, Georgia
Clear Cell Renal Cell Carcinoma
View Study & Checklist βStudy of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
π Exelixis Clinical Site #208 β Phoenix, Arizona
Hepatocellular Carcinoma
View Study & Checklist βA Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
π USC Norris Comprehensive Cancer Center ( Site 0060) β Los Angeles, California
Renal Cell Carcinoma (RCC)
View Study & Checklist βA Phase II Trial of Cabozantinib With Patients With Refractory GCTs
π Indiana University Melvin & Bren Simon Cancer Center β Indianapolis, Indiana
Germ Cell Tumor
View Study & Checklist βA Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
π Cedars-Sinai Medical Center β Los Angeles, California
ccRCC
View Study & Checklist βCabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
π Children's Hospital of Alabama β Birmingham, Alabama
Adrenal Cortical Carcinoma
View Study & Checklist βA Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
π Exelixis Clinical Site #2 β Newport Beach, California
Differentiated Thyroid Cancer
View Study & Checklist βStudy of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
π Providence Portland Cancer Institute - Franz Clinic β Portland, Oregon
Neuroendocrine Tumors
View Study & Checklist βCabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
π Beth Israel Deaconess Medical Center β Boston, Massachusetts
Papillary Renal Cell Carcinoma
View Study & Checklist βTesting the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
π City of Hope Comprehensive Cancer Center β Duarte, California
Differentiated Thyroid Gland Carcinoma
View Study & Checklist βCabozantinib in High Grade Neuroendocrine Neoplasms
π Washington University School of Medicine β St Louis, Missouri
High Grade Neuroendocrine Neoplasms
View Study & Checklist βA Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
π The University of Kansas Cancer Center - Westwood β Kansas City, Kansas
Lung Cancer
View Study & Checklist βA Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)
π Ryan Nguyen β Chicago, Illinois
Metastatic Squamous Non-Small Cell Lung Carcinoma
View Study & Checklist βA Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
π Research Site β Birmingham, Alabama
Clear Cell Renal Cell Carcinoma
View Study & Checklist βTesting the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
π Mayo Clinic Hospital in Arizona β Phoenix, Arizona
Locally Advanced Adrenal Cortical Carcinoma
View Study & Checklist βTrial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
π Fox Chase Cancer Center β Philadelphia, Pennsylvania
Metastatic Renal Cell Carcinoma
View Study & Checklist βCabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
π University of Kansas Cancer Center β Westwood, Kansas
Gastric Cancer
View Study & Checklist βStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
π Research Site β Gilbert, Arizona
Metastatic Clear Cell Renal Cell Carcinoma
View Study & Checklist βA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
π Local Institution - 0178 β Palo Alto, California
Advanced Renal Cell Carcinoma (RCC)
View Study & Checklist βCabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
π Huntsman Cancer Institute/University of Utah β Salt Lake City, Utah
Castration-Resistant Prostate Carcinoma
View Study & Checklist βA Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
π City of Hope β Duarte, California
Advanced Hepatocellular Carcinoma
View Study & Checklist βPan Tumor Rollover Study
π Local Institution - 0220 β Huntsville, Alabama
Cancer
View Study & Checklist βAtezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
π Dana-Farber Cancer Institute β Boston, Massachusetts
Locally Advanced Osteosarcoma
View Study & Checklist βA Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
π Johns Hopkins University (Data Collection Only) β Baltimore, Maryland
Metastatic Renal Cell Carcinoma
View Study & Checklist βKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
π Mayo Clinic Comprehensive Cancer Center β Phoenix, Arizona
Solid Tumors With HRAS Alterations
View Study & Checklist βExtension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
π Beth Israel Deaconess Medical Center ( Site 0107) β Boston, Massachusetts
Von Hippel-Lindau Disease
View Study & Checklist βCabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
π Emory University Hospital/Winship Cancer Institute β Atlanta, Georgia
Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
View Study & Checklist βPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
π M D Anderson Cancer Center β Houston, Texas
Advanced Breast Carcinoma
View Study & Checklist βCabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
π Memorial Sloan Kettering Basking Ridge β Basking Ridge, New Jersey
Non-Small Cell Lung Cancer
View Study & Checklist βTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Autoimmune Disease
View Study & Checklist βAutologous Dendritic Cell Vaccine in Kidney Cancer
π UPMC Department of Urology β Pittsburgh, Pennsylvania
Carcinoma, Renal Cell
View Study & Checklist βModulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
π The University of Texas M. D. Anderson Cancer Center β Houston, Texas
Clear Cell Renal Cell Carcinoma
View Study & Checklist βComparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Metastatic Digestive System Neuroendocrine Tumor G1
View Study & Checklist βTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Bladder Adenocarcinoma
View Study & Checklist βStudy of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
π Anchorage Associates in Radiation Medicine β Anchorage, Alaska
Refractory Differentiated Thyroid Gland Carcinoma
View Study & Checklist βCabozantinib for Patients With Recurrent or Progressive Meningioma
π Miami Cancer Institute at Baptist Health, Inc. β Miami, Florida
Meningioma
View Study & Checklist βCabozantinib to Treat Recurrent Liver Cancer Post Transplant
π Princess Margaret Cancer Centre β Toronto, Ontario
Hepatocellular Carcinoma
View Study & Checklist βDose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
π Huntsman Cancer Institute at University of Utah β Salt Lake City, Utah
Metastatic Castration-resistant Prostate Cancer
View Study & Checklist βA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
π Alaska Oncology and Hematology ( Site 0133) β Anchorage, Alaska
Renal Cell Carcinoma
View Study & Checklist βAtezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
π Mayo Clinic in Arizona β Scottsdale, Arizona
Locally Advanced Hepatocellular Carcinoma
View Study & Checklist βStudy of Cabozantinib With Selumetinib for Plexiform Neurofibromas
π Childrens of Alabama β Birmingham, Alabama
Neurofibromatosis 1
View Study & Checklist βGenetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
π City of Hope National Medical Center β Duarte, California
Advanced Clear Cell Renal Cell Carcinoma
View Study & Checklist βMetastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
π University of Alabama at Birmingham (Children's of Alabama) β Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist βCabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
π Chao Family Comprehensive Cancer Center, University of California, Irvine β Orange, California
Hepatocellular Carcinoma
View Study & Checklist βCabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
π University of California San Francisco β San Francisco, California
Ewing Sarcoma
View Study & Checklist βSequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
π UT Southwestern Medical Center β Dallas, Texas
RCC
View Study & Checklist βAdding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
π Highlands Oncology Group - Fayetteville β Fayetteville, Arkansas
Advanced Clear Cell Renal Cell Carcinoma
View Study & Checklist βBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
π Mayo Clinic Hospital in Arizona β Phoenix, Arizona
Clinical Stage III Cutaneous Melanoma AJCC v8
View Study & Checklist βA Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
π M D Anderson Cancer Center β Houston, Texas
Brain Metastases
View Study & Checklist βTesting the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein Ξ²-Catenin, The SAPHIRE Trial
π UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care β Irvine, California
Advanced Hepatocellular Carcinoma
View Study & Checklist βPhase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naΓ―ve Patients With Advanced Clear Cell RCC
π MD Anderson Cancer Center β Houston, Texas
Advanced Cancer
View Study & Checklist βCabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
π Emory University Hospital Midtown β Atlanta, Georgia
Locally Advanced Adrenal Cortex Carcinoma
View Study & Checklist βTesting the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Metastatic Renal Cell Carcinoma
View Study & Checklist βA Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
π Children's Hospital of Alabama/UAB β Birmingham, Alabama
Neuroblastoma
View Study & Checklist β